Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Aquaculture biotechnology business Benchmark said it expected adjusted core earnings to be 'significantly ahead' of market expectations.
For the year ended 30 September 2021, current market consensus for earnings before, interest, taxes, depreciation, and amortisation, or EBITDA, was £15.9 million.
All business divisions delivered performance above the board's expectations in September, the company said.